World Journal of Dentistry

Register      Login

VOLUME 15 , ISSUE 2 ( February, 2024 ) > List of Articles

ORIGINAL RESEARCH

Chemopreventive Role of Sulindac Sulfone on 4-nitroquinoline 1-oxide-induced Head and Neck Squamous Cell Carcinogenesis in Rats

Nivethitha Karuppiah, S Gheena, Pratibha Ramani, Abilasha Ramasubramanian

Keywords : β-catenin, E-cadherin, Head and neck squamous cell carcinoma, Histopathology, Immunohistochemistry, 4-nitroquinoline 1-oxide, Sulindac sulfone

Citation Information : Karuppiah N, Gheena S, Ramani P, Ramasubramanian A. Chemopreventive Role of Sulindac Sulfone on 4-nitroquinoline 1-oxide-induced Head and Neck Squamous Cell Carcinogenesis in Rats. World J Dent 2024; 15 (2):141-149.

DOI: 10.5005/jp-journals-10015-2370

License: CC BY-NC 4.0

Published Online: 02-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aim: The objective of this study was to investigate the efficacy of sulindac sulfone against head and neck squamous cell carcinoma (HNSCC) induced with 4-nitroquinoline 1-oxide (4NQO) in a murine model. Materials and methods: A total of 18 male Wistar albino rats were divided into three groups (n = 6) as follows—group I (control), which received normal drinking water; group II (test), which received 4-NQO through topical application and drinking water; and group III (treatment) which received 4-NQO followed by with sulindac sulfone (100 mg/kg). At the end of the experimental period in the 21st week, the rats were sacrificed, the tissues were collected, formalin-fixed, and sections were made. Histopathological analysis and immunohistochemical (IHC) expression of e-cadherin and β-catenin were analyzed. Results: Histopathological analysis showed improvement in the histopathological parameters in the treatment group; however, it was not statistically significant. IHC analysis showed increased β-catenin (p = 0.296) and increased E-cadherin expression (p = 0.002) in treatment compared to the test group. Conclusion: The study data indicate that sulindac sulfone displayed showed effective chemoprotective activity in 4-NQO induced HNSCC mediated by improvement in histopathology parameters and upregulation in the expression of E-cadherin and β-catenin. Clinical significance: Sulindac sulfone elicits potent chemoprotective activity against 4-NQO provoked HNSCC mediated by activation of pro-inflammatory condition and apoptosis.


PDF Share
  1. Lutzky VP, Moss DJ, Chin D, et al. Biomarkers for cancers of the head and neck. Clin Med Ear Nose Throat 2008;1:5–15. DOI: 10.4137/CMENT.S1051
  2. Sarma H, Jahan T, Sharma HK. Progress in drug and formulation development for the chemoprevention of oral squamous cell carcinoma: a review. Recent Pat Drug Deliv Form 2019;13(1):16–36. DOI: 10.2174/1872211313666190222182824
  3. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209–249. DOI: 10.3322/caac.21660
  4. Chole RH, Patil RN, Basak A, et al. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. J Cancer Res Ther 2010;6(4):487–491. DOI: 10.4103/0973-1482.77106
  5. DeFreitas Cordeiro-Silva M, Oliveira ZF, De Podestá JR, et al. Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma. Mol Biol Rep 2011;38(8):5435–5441. DOI: 10.1007/s11033-011-0698-1
  6. Marichalar-Mendia X, Acha-Sagredo A, Rodriguez-Tojo MJ, et al. Alcohol-dehydrogenase (ADH1B) Arg48His polymorphism in Basque Country patients with oral and laryngeal cancer: preliminary study. Anticancer Res 2011;31(2):677–680.
  7. Morse DE, Psoter WJ, Cleveland D, et al. Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control 2007;18(9):919–929. DOI: 10.1007/s10552-007-9026-4
  8. Zygogianni AG, Kyrgias G, Karakitsos P, et al. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol 2011;3(1):2. DOI: 10.1186/1758-3284-3-2
  9. Subapriya R, Thangavelu A, Mathavan B, et al. Assessment of risk factors for oral squamous cell carcinoma in Chidambaram, southern India: a case-control study. Eur J Cancer Prev 2007;16(3):251–256. DOI: 10.1097/01.cej.0000228402.53106.9e
  10. Acharya S, Singh S, Bhatia S. Association between smokeless tobacco and risk of malignant and premalignant conditions of oral cavity: a systematic review of Indian literature. J Oral Maxillofac Pathol 2021;25(2):371–372. DOI: 10.4103/0973-029X.325258
  11. Madani AH, Dikshit M, Bhaduri D. Risk for oral cancer associated to smoking, smokeless and oral dip products. Indian J Public Health 2012;56(1):57–60. DOI: 10.4103/0019-557X.96977
  12. Lin WJ, Jiang RS, Wu SH, et al. Smoking, alcohol, and betel quid and oral cancer: a prospective cohort study. J Oncol 2011;2011:525976. DOI: 10.1155/2011/525976
  13. Balaram P, Sridhar H, Rajkumar T, et al. Oral cancer in Southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 2002;98(3):440–445. DOI: 10.1002/ijc.10200
  14. Borse V, Konwar AN, Buragohain P. Oral cancer diagnosis and perspectives in India. Sens Int 2020;1:100046. DOI: 10.1016/j.sintl.2020.100046
  15. Suvarna K, Vijayashree Priyadharsini J, Gheena S, et al. The impact of CA9 gene polymorphism (RS2071676) on oral cancer susceptibility - an in-silico study. Int J Curr Res Rev 2020:02–08. DOI: 10.31782/IJCRR.2020.SP101
  16. Y D, Ramani P, Yuwanati M, et al. MicroRNA profiling in circulating exosomes in oral squamous cell carcinoma: a systematic review: Cureus 2023;15(8):e43235. DOI: 10.7759/cureus.43235
  17. Piazza GA, Alberts DS, Hixson LJ, et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 1997;57(14):2909–2915.
  18. Wang Q, Fan LY, He J, et al. Inhibitory effect of sulindac against chemically-induced primary colonic tumors by N-methyl-N-nitrosourea in mice. World J Gastroenterol 2011;3(1):16. DOI: 10.3748/wjg.v3.i1.16
  19. Sauter A, Soulsby H, Hormann K, et al. Sulindac sulfone induces a decrease of beta-catenin in HNSCC. Anticancer Res 2010;30(2):339–343.
  20. Li N, Xi Y, Tinsley HN, et al. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling. Mol Cancer Ther 2013;12(9):1848–1859. DOI: 10.1158/1535-7163.MCT-13-0048
  21. Aono Y, Horinaka M, Iizumi Y, et al. Sulindac sulfone inhibits the mTORC1 pathway in colon cancer cells by directly targeting voltage-dependent anion channel 1 and 2. Biochem Biophys Res Commun 2018;505(4):1203–1210. DOI: 10.1016/j.bbrc.2018.10.050
  22. Reddy BS, Kawamori T, Lubet RA, et al. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res 1999;59(14):3387–3391.
  23. Kanojia D, Vaidya MM. 4-Nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncol 2006;42(7):655–667. DOI: 10.1016/j.oraloncology.2005.10.013
  24. Lee CW, Rickman B, Rogers AB, et al. Combination of sulindac and antimicrobial eradication of helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res 2009;69(20):8166–8174. DOI: 10.1158/0008-5472.CAN-08-3856
  25. Mladenova D, Pangon L, Currey N, et al. Sulindac activates NF-κB signaling in colon cancer cells. Cell Commun Signal 2013;11(1):73. DOI: 10.1186/1478-811X-11-73
  26. Mahmoud NN, Boolbol SK, Dannenberg AJ, et al. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis 1998;19(1):87–91. DOI: 10.1093/carcin/19.1.87
  27. Scheper MA, Nikitakis NG, Chaisuparat R, et al. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma. Neoplasia 2007;9(3):192–199. DOI: 10.1593/neo.06781
  28. Cai ZG, Shi XJ, Gao Y, et al. B-catenin expression pattern in primary oral squamous cell carcinoma. Chin Med J 2008;121(19):1866–1870. DOI: 10.1097/00029330-200810010-00003
  29. Naim R, Chang RC, Schultz J, et al. Chemopreventive alteration of the cell-cell adhesion in head and neck squamous cell cancer. Oncol Rep 2006;16(2):273–277. DOI: 10.3892/or.16.2.273
  30. Greenspan EJ, Nichols FC, Rosenberg DW. Molecular alterations associated with sulindac-resistant colon tumors in ApcMin/+ mice. Cancer Prev Res 2010;3(9):1187–1197. DOI: 10.1158/1940-6207.CAPR-09-0270
  31. Mahomed F, Altini M, Meer S. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Dis 2007;13(4):386–392. DOI: 10.1111/j.1601-0825.2006.01295.x
  32. López-Verdín S, Martínez-Fierro ML, Garza-Veloz I, et al. E-cadherin gene expression in oral cancer: clinical and prospective data. Med Oral Patol Oral Cir Bucal 2019;24(4):e444–e451. DOI: 10.4317/medoral.23029
  33. Gurpinar E, Grizzle WE, Piazza GA. COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs. Front Oncol 2013;3:181. DOI: 10.3389/fonc.2013.00181
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.